PUBLICATIONS
- Arceri V, Kane MP. Hyperthyroidism. In Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach, 6th edition (a companion textbook to the 6th edition of Chisholm-Burns et al. Pharmacotherapy Principles and Practice); Sept 2022.
- Kane MP, Bakst G. Thyroid Disorders. In DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. eds. Pharmacotherapy: A Pathophysiologic Approach, 12e New York, NY: McGraw-Hill; 2022; Chapter 96: Thyroid Disorders; 1-50.
- Cibotaru D, Celestin MN, Kane MP, Musteata M. Comparison of Liquid-Liquid Extraction, Microextraction, and Ultrafiltration for Measuring Free Concentration of Testosterone and Phenytoin. Bioanalysis. 2022;14(4): 195-204.
- Quinn HB, Busch RS, Kane MP. The Occurrence and Burden of Hypophosphatasia in an Ambulatory Care Endocrinology Practice. Endocrine Practice, 2021;27:1189-1192.
- Cibotaru D, Celestin MN, Kane MP, Musteata M. Method for Simultaneous Determination of Free Concentration, Total Concentration, and Plasma Binding Capacity in Clinical Samples. J Pharm Sci 2021;110:1401-11.doi: 10.1016/j.xphs.2020.12.001.
- Kane MP, Triplitt C, Solis-Herrera C. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. Am J Health Syst Pharm . 2021 Mar 18;78(7):556-567. doi: 10.1093/ajhp/zxaa413.
- Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
- Kane MP, Triplitt C, Solis-Herrera C. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. Accepted for publication, American Journal of Health-System Pharmacy.
- Kuchis MM, Eldeiry A, Busch RS, Racz MJ, Kane MP. Real-World Long-Term Safety and Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors. Endocr Pract (Abstract). 2020;26(suppl 2):166-167.
- Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2020 ed. Lenexa, KS: American College of Clinical Pharmacy, 2020:47-108.
- Kuchis M, Kane MP. iForumRX PodCast and Script - Subclinical Hypothyroidism: Don’t Let the Numbers Fool You: Levothyroxine Isn’t a Cure-all. March 3, 2020 https://iforumrx.org/commentary/don%E2%80%99t-let-numbers-fool-you-levo…
- McGreevy JL, Kane MP, Busch RS, Bakst G, ElDeiry SS. A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report. J Am Pharm Assoc. 2019;59(4):593-597.
- Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
- Farina K, Kane MP. Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the Literature. J Pharm Pract. 2019 Jul 3:897190019850929. doi: 10.1177/0897190019850929
- Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. Updates in Therapeutics ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:631-93.
SELECTED POSTER/PLATFORM PRESENTATIONS
- Arceri V, Kane MP, Quinn HB, Telese M, Racz M, Busch RS. Abaloparatide implementation and follow-up: Real-world results of a pharmacist-run anabolic osteoporosis clinic. Poster presented at the 2022 Endocrine Society Annual Meeting, Atlanta, GA, June 11, 2022.
- Updates in Diabetes Management: The Elderly. Presented at the New York American Society of Consultant Pharmacists Mid-State Chapter Meeting, Syracuse, NY, June 1, 2022.
- The Evolving Treatment Paradigm for Osteoporosis: The Integral Role of the Pharmacist in Optimizing Care. Pharmacy Times CE, Cranbury, NJ, April 27, 2022.
- Quinn HB, Busch RS, Kane MP. Abstract Number: 8734 The Endocrine Society Annual Meeting. Abstract Title: The Prevalence and Burden of Hypophosphatasia in an Ambulatory Endocrinology Practice. Poster session: P08. Parathyroid and Rare Bone Disorders. Took place online, ENDO 2021, March 20-23, 2021.
- PSSNY/CPESN Diabetes Self Care Management (DSMES) Boot Camp. Update on Diabetes: Medications, Clinical Guidelines, and Treatment Recommendations. Presented Nov 8, 2020, virtual presentation.
- Kuchis MM, Eldeiry A, Busch RS, Racz M, Kane MP. Real-world long-term safet y and efficacy of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. EMBRAACE 2020: The AACE 29th Annual Scientific & Clinical Congress; Washington, DC May 10, 2020. (On-line presentation due to COVID-19 pandemic).
- ACCP/ASHP 2020 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented March 5, 2020, Henderson, NV.
- Current Issues in Hypothyroidism. The Nurse Practitioner Association New York State 35th Annual Conference. Presented October 19, 2019, Verona, NY.
- ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented May 3, 2019, Minneapolis, MN.
- McGreevy JL, Cherian S, Kane MP, Busch RS, Racz M. A real-world GLP-1 receptor agonist switch study. Presented at the ACCP/ASHP Updates in Therapeutics 2019 meeting, St. Louis College of Pharmacy, St. Louis, Missouri, April 28, 2019.
RESEARCH GRANTS
Abaloparatide implementation and follow-up: Real-world results of a pharmacist-run anabolic osteoporosis clinic. Kane MP, Arceri V, Quinn H, Busch RS. Radius Pharmaceuticals, $42,640; Dec 2021.
The Prevalence and Burden of Hypophosphatasia in an Ambulatory Care Endocrinology Practice. Kane MP, Quinn H, Busch RS. Awarded $42,640; Alexion Pharmaceuticals; July 2020.
Simultaneous Determination of Free, Total, and Normalized Concentrations of Bioactive Compounds. Musteata FM, Kane MP. National Institutes of Health. Grant Number: 1R15GM126510-01 FAIN: R15GM126510. Awarded $480,000. 09/01/2018 – 08/31/2021.